Preparation and the release characteristic in vitro of arsenic trioxide albumin nanospheres

Jie ZHOU,Fu-qing ZENG,Xiang GAO,Shu-Sheng XIE,Shu-li WEI
DOI: https://doi.org/10.3321/j.issn:1003-3734.2005.01.014
2005-01-01
Abstract:Objective:To prepare and characterize arsenic trioxide albumin nanospheres (As_2O_3-BSA-NS). Methods: As_2O_3-BSA-NS was prepared by a chemical cross-inking technique. The optimal microsphere formulation was established based on the defined factors (DF) with the particle size (1μm)distribution, loading dose and drug compounding efficiency. The final arsenic trioxide albumin nanospheres were prepared by an orthogonal manufacture protocol including W/O ratio, high distribution rate, BSA concentration and blending solidification time. The release of the As_2O_3 from the nanosphere was assessed by a dissolution test in vitro. Results:The study showed that the most factors to prepare the nanosphere is the distribution rate (P0.01) and then BSA concentration as well as W/O ratio (P0.05). The blending solidification time had not notable contributions on the defined factors (P0.05). The slower sustained release of arsenic trioxide albumin nanosphere was attainable compared with the conventional dosage form of arsenic trioxide. Conclusion: The optimal As_2O_3-BSANS features the sustained release.
What problem does this paper attempt to address?